Developer of an immune system technology designed to provide treatments for oncology and auto-immune disorders.
Discovery Tools (Healthcare)📍 New York, NYFounded 2018
Current Valuation
$960M
as of 2021-Q4
PRIVATE
Developer of an immune system technology designed to provide treatments for oncology and auto-immune disorders.
Company Profile
Founded
2018
HQ
New York, NY
Employees
180
Total Raised
$583.52M
Last Round
Series C — $204M (Dec 2021)
IPO Status
private
Fundraising Status
Series C · $204M · 4y 8mo ago
privateTotal raised $583.52M
Secondary Market
Implied price / share
$127.25
Last round price / share
$186.34
vs last round
-31.7%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.